Lp (a) is a unique class of lipoprotein particles that exhibits a considerable size
heterogeneity resulting from the size polymorphism of apo (a), its unique protein component …

There are many ways to measure the dispersion of a random variable. One such method
uses the concept of peakedness. If the random variable X is symmetric about a point μ, then …

Coronary artery disease is the main cause of death worldwide. Lipoprotein (a)[Lp (a)], is an
independent risk factor for coronary artery disease in which concentrations are genetically …

Recombinant human growth hormone (rhGH) is now used routinely in the treatment of
congenital and acquired GH deficiency (GHD). Additional indications for long-term …

Cardiovascular disease (CVD) is the leading cause of mortality worldwide and
atherosclerosis is the primary underlying cause. Elevated blood leukocyte levels are …

Abstract Background: The apolipoprotein (a)[apo (a)] gene is a major predictor of plasma
lipoprotein (a) concentrations, an independent risk factor for cardiovascular disease. The …

Abstract Lipoprotein (a)(Lp (a)) is a macromolecular complex consisting of LDL and the
characteristic apolipoprotein (a)(apo (a)). Lp (a) occurs as a quantitative genetic trait with …

Fragments of apolipoprotein (a)[apo (a)], the distinctive glycoprotein of lipoprotein (a)[Lp (a)],
are present in human plasma and urine and have been implicated in the development of …

In this article, key events of the history of lipoprotein (a)(Lp (a)) research from its discovery as
a genetic trait in human plasma by the Norwegian scientist Kare Berg in 1963 until the …

Background Levels of lipoprotein (a), Lp (a), a genetically regulated independent
cardiovascular risk factor present in humans and Old World monkeys, are impacted by the …